inhibitory glp 1 Glucagon-like peptide-1 Unlocking the potential of GLP-1

This study is the first to examine the potential cardiovascular benefits of these drugs in a high-risk population of patients with both obesity and an autoimmune diseaseboth of which are associated with a higher risk of cardiovascular and blood clot events

Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway

S.MassaroJ

Fatigue on tirzepatide and semaglutide-related fatigue can create a cycle where poor sleep worsens digestive symptoms, digestive discomfort disrupts sleep further, and the combined effect makes side effects harder to tolerate

As a result, the method is gentler, causes fewer swallowing difficulties, and is considerably less invasive

Simultaneously, this study highlights the critical considerations for clinicians in administering these medications, including long-term safety, efficacy, potential adverse effects, and overall clinical utility